Molecular formula: | C22H25FN4O2 |
Average mass: | 396.466 |
Monoisotopic mass: | 396.196154 |
ChemSpider ID: | 4486268 |
Double-bond stereo
1H-Pyrrole-3-carboxamide, 5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-N-[2-(1-pyrrolidinyl)ethyl]-
[ACD/Index Name]356068-94-5
[RN]5-[(Z)-(5-Fluor-2-oxo-1,2-dihydro-3H-indol-3-yliden)methyl]-2,4-dimethyl-N-[2-(1-pyrrolidinyl)ethyl]-1H-pyrrol-3-carboxamid
[German]
[ACD/IUPAC Name]5-[(Z)-(5-Fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-N-[2-(1-pyrrolidinyl)ethyl]-1H-pyrrole-3-carboxamide
[ACD/IUPAC Name]5-[(Z)-(5-Fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidène)méthyl]-2,4-diméthyl-N-[2-(1-pyrrolidinyl)éthyl]-1H-pyrrole-3-carboxamide
[French]
[ACD/IUPAC Name]5-{[(3Z)-5-fluoro-2-oxo-2,3-dihydro-1H-indol-3-ylidene]methyl}-2,4-dimethyl-N-[2-(pyrrolidin-1-yl)ethyl]-1H-pyrrole-3-carboxamide
59L7Y0530C
[UNII]Toceranib
[INN] [USAN]tocéranib
[French]
[INN]toceranib
[Spanish]
[INN]toceranibum
[Latin]
[INN](Z)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-N-(2-(pyrrolidin-1-yl)ethyl)-1H-pyrrole-3-carboxamide
(Z)-5-(5-Fluoro-2-oxo-2,3-dihydro-1H-indol-3-ylidenemethyl)-2,4-dimethyl-N-[2-(1-pyrrolidinyl)ethyl]-1H-pyrrole-3-carboxamide
(Z)-5-(5-Fluoro-2-oxo-2,3-dihydro-1H-indol-3-ylidenemethyl)-2,4-dimethyl-N-[2-(1-pyrrolidinyl)ethyl]-1H-pyrrole-3-carboxamide;SU-11654
1795134-78-9
[RN]356068-94-5 (free base)
5-(5-Fluoro-2-oxo-1,2-dihydro-indol-3-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-pyrrolidin-1-yl-ethyl)-amide
5-(5-Fluoro-2-oxo-1,2-dihydroindol-(3Z)-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-(pyrrolidin-1-yl)ethyl)amide
5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-N-[2-(1-pyrrolidinyl)ethyl]-1H-pyrrole-3-carboxamide
5-[(Z)-(5-fluoro-2-keto-indolin-3-ylidene)methyl]-2,4-dimethyl-N-(2-pyrrolidin-1-ylethyl)-1H-pyrrole-3-carboxamide
5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-N-[2-(pyrrolidin-1-yl)ethyl]-1H-pyrrole-3-carboxamide
5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-N-(2-pyrrolidin-1-ylethyl)-1H-pyrrole-3-carboxamide
5-[(Z)-(5-fluoro-2-oxo-3-indolinylidene)methyl]-2,4-dimethyl-N-(2-1-pyrrolidinylethyl)-1H-pyrrole-3-carboxamide
5-[(Z)-(5-fluoro-2-oxo-indolin-3-ylidene)methyl]-2,4-dimethyl-N-(2-pyrrolidin-1-ylethyl)-1H-pyrrole-3-carboxamide
EGFR_HUMAN
Epidermal growth factor receptor
FGFR1_HUMAN
Fibroblast growth factor receptor 1
Methyl 2-oxoacetate
MFCD16038046
[MDL number]Palladia
[Trade name]PGFRB_HUMAN
tocéranib
toceranib discontinued pfizer patent issues
Toceranib free base
Toceranib(SU 11654; PHA 291639)
Toceranib-d8
toceranibum
VGFR2_HUMAN
тоцераниб
[Russian]توسيرانيب
[Arabic]托西尼布
[Chinese]